Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
AZD9291 BP EP USP CAS 1421373-66-1 Manufacturers and Suppliers - Price ...
Sonwu Supply API Pharmaceutical Intermediate Osimertinib Azd9291 ...
AZD9291 (Osimertinib) | Certificate of Analysis
Method for preparing AZD9291 - Eureka | Patsnap
AZD9291 binding mode and structure. A, Structural model showing the ...
AZD9291 非小细胞肺癌耐药克星 - 华夏肿瘤康复网
AZD9291 inhibits EGFR downstream signaling pathways and induces ...
Structural Basis of AZD9291 Selectivity for EGFR T790M | Journal of ...
Acquired resistance to AZD9291 as an upfront treatment is dependent on ...
AZD9291 | CAS:1421373-65-0 | 上海芮晖化工科技有限公司
The third-generation EGFR inhibitor AZD9291 overcomes primary ...
The combination of AZD9291 with a MEK inhibitor effectively inhibits ...
AZD9291 Resistance Reversal Activity of a pH‐Sensitive Nanocarrier Dual ...
Synergistic effects of Bcl-2 inhibitors with AZD9291 on overcoming the ...
AZD9291 inhibits tumor growth in xenograft models through degradation ...
AZD9291 treatment is effective in erlotinib-resistant cells and induces ...
New EGFR inhibitor AZD9291 shows promising activity in treatment ...
Expression of AXL and sensitivity to AZD9291 in non-small-cell lung ...
Rifampicin and AZD9291 for Non-Small Cell Lung Cancer Clinical Trial ...
AZD 9291 Supplier | CAS 1421373-65-0 | AZD9291 | Tocris Bioscience
The combination of AZD9291 and HQP8361 enhances modulation of ...
Method for industrially synthesizing AZD9291 - Eureka | Patsnap
Acquired resistance to AZD9291 as first-line treatment is mediated by ...
AZD9291 | CAS:1421373-66-1 | 北京沃凯生物科技有限公司
1421373-65-0 AZD9291 - Watson International Ltd
Additional characteristics of AZD9291 in vitro. A, AZD9291 demonstrates ...
AZD9291 enhances ubiquitination and proteosomal degradation of ...
Figure 3 from High efficacy of third generation EGFR inhibitor AZD9291 ...
AZD9291 (Osimertinib) (Osimertinib; Mereletinib) | CAS 1421373-65-0 ...
JNJ-61186372 in combination with AZD9291 was effective and durable in ...
(PDF) AZD9291 Resistance Reversal Activity of a pH‐Sensitive ...
AZD9291 inhibits GBM tumorigenesis in vivo. a Mice bearing U87 ...
Acquired resistance to mutant-selective EGFR inhibitor AZD9291 is ...
Harmine increases the apoptosis that is induced by AZD9291 in EGFR ...
In vivo, combination of AZD9291 and selumetinib can overcome acquired ...
XRD patterns of AZ91D powder and AZ91D coatings deposited at different ...
High efficacy of third generation EGFR inhibitor AZD9291 in a ...
Mechanisms of Acquired Resistance to AZD9291 - Journal of Thoracic Oncology
AZD9291 Intermediates Synthesis EGFR Inhibitor CAS 1075705-01-9 - China ...
The combination of AZD9291 and HQP8361 stabilizes Bim protein (A and ...
(PDF) Resistance Mechanisms to AZD9291 and Rociletinib—Letter
Caffeic acid phenethyl ester surmounts acquired resistance of AZD9291 ...
AZD-9291 API – High-Quality EGFR Inhibitor Supplier
Self-optimisation of the final stage in the synthesis of EGFR kinase ...
AZD9291中间体2 1421372-94-2现货报价-盖德化工网
AZD9291中间体3 1421372-67-9 - ChemicalBook
osimertinib (AZD9291) Manufacturer | HUAWAVE BIOTECH
化合物 AZD9291-345|T30268|TargetMol - ChemicalBook
阿斯利康新药AZD9291用于耐药后的非小细胞肺癌有效 - 华夏肿瘤康复网
Osimertinib (AZD9291) | CAS:1421373-65-0 | Manufacturer ChemFaces
AZD9291; Osimertinib supplier | CAS No:1421373-65-0 |EGFR inhibitor AOBIOUS
AZD9291-resistant PC9 cells show increased SerpinB5 levels after ...
(PDF) AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated ...
1421372-66-8｜AZD9291 intermediate｜Shandong Shining Pharm Co.,Ltd.
Osimertinib (AZD-9291) | Mutant-Selective EGFR Inhibitor | MedChemExpress
奥希替尼（AZD9291）的药理作用和耐药性 - 知乎
AZD-9291 - EGFR Mutant Inhibitor for Cancer Research | APExBIO
API SYNTHESIS INTERNATIONAL: AZD 9291, Osimertinib, Third-generation ...
AZD9291甲磺酸盐—1421373-66-1 - ChemicalBook
全球首款高端奥希替尼（AZD9291）仿制药在法玛制药公司投产_KINGKEN PHARMACEUTICALS | 京品(柬埔寨)药业有限公司
The novel MET inhibitor, HQP8361, possesses single agent activity and ...
Overexpression of PLAC8 promotes AZD9291-resistance in NSCLC cells. (A ...
AZD9291-resistant PC9 cells exhibit persistent ERK activation. (A ...
Osimertinib (AZD9291) is an Orally Active EGFR Inhibitor for Lung ...
Efficacy of SHR‐A1403 on AZD9291‐resistant HA1 xenografts... | Download ...
AZD9291(甲磺酸盐) CAS#: 1421373-66-1
蔬果汁先生的抗癌生活記事: 第二次標靶治療 (AZD9291)
Osimertinib mesylate (AZD-9291 mesylate) | Mutant-Selective EGFR ...
AZD9291耐药新出路—AZD9291联合AZD6244现曙光 - 知乎
Osimertinib (AZD9291) decreases programmed death ligand-1 in EGFR ...
1421373-66-1 AZD9291甲磺酸盐;甲磺酸迈瑞替尼/奥希替尼精品试剂杂质标准品系列|结构式|中间体|科研材料|实验试剂-鼎信通 ...
奥斯替尼(AZD9291)|1421373-65-0_奥斯替尼杂质系列_恒丰万达药物杂质网
产品展示_山东轩鸿生物医药有限公司
肺癌逆天神藥AZD9291中國獲批上市（史上最全解讀） - 每日頭條
Clin Cancer Res：AZD9291联合MEK抑制剂克服包含C797S的获得性耐药-MedSci.cn
Effect of high dose-AZD9291 treatment after acquisition of EGFR-TKI ...
Activity and antitumor efficiency of CP@NP-cRGD in AZD9291-resistant ...
肺癌患者重磅福音：AZD9291耐藥有法子了？！ - 每日頭條
奥希替尼（AZD9291 ）中间体 - 山东轩德医药科技有限公司
PLAC8 expression is upregulated in AZD9291-resistant NSCLC cell lines ...
Osimertinib (AZD9291) 是选择性 EGFR 抑制剂｜MedChemExpress (MCE)_VanR_insFQEA_Calu
Acquisition of H1975 and HCC827 cells resistant to AZD9291. The drug ...
AZD9291！AZD9291！！哪里买？！价格 100无 产地：湖北 品牌：达尔邦 厂家：武汉达尔邦医疗科技有限公司
AZD9291-resistant PC9 cells contain an HRAS mutation. (A) Summary of ...
AZD9291耐药新出路：AP26113联合爱必妥逆袭？！
AZD9291甲磺酸盐
AZD-9291价格 厂家：广州贝尔卡生物科技有限公司
【奥希替尼,奥西替尼,泰瑞沙,osimertinib,TAGRISSO,azd9291,LuciOsim（老挝卫生部批准）】说明书_代购价格 ...
EGFR (epidermal growth factor receptor) TKI (tyrosine kinase inhibitor ...
AZD9291是治疗EGFR T790M突变阳性转移性的非小细胞肺癌的药物-康安途海外医疗
迈瑞替尼AZD9291 1421373-65-0--杭州众昌科技有限公司
注意！碧康「黑盒」AZD9291（Tagrix）換新包裝了 - 每日頭條
奥希替尼|AZD9291 | 泰瑞沙黑盒/INCEPTA_印度肿瘤药房！
:%0A%0ARifampicin%20and%20AZD9291%20for%20Non-Small%20Cell%20Lung%20Cancer.png?md=1)
